Daily Archives: April 1, 2020

iTeos Therapeutics Closes $125 Million Series B2 Financing

iTeos Therapeutics Closes $125 Million Series B2 Financing
 
– Proceeds support advancing clinical development of next-generation cancer immunotherapies targeting A2A adenosine receptor and anti-TIGIT immune checkpoint –

– Oversubscribed round co-led by new investors RA Capital Management and Boxer Capital –

– New investors Janus Henderson Investors, RTW Investments and Invus also participated along with previous Series B investors including MPM Capital and HBM Partners –
 
Cambridge, MA and Gosselies, Belgium – April 1, 2020 – iTeos Therapeutics Inc.

Philips enables hospitals and GPs to remotely screen and monitor patients with COVID-19

April 1, 2020

  • Philips provides healthcare institutions with telehealth solution to process high volume coronavirus-related healthcare requests via online screening, and supports healthcare providers in the use of external call centers to offer the correct care to patients
  • If medically justified, patients infected with COVID-19 can be remotely monitored via automated questionnaires about their home situation and state of health

Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it can help general practitioners and healthcare institutions manage the increased patient flows resulting from the COVID-19 outbreak through a dedicated and scalable telehealth solution that facilitates the use of online screening, follow-up questionnaires and monitoring, and external call center collaborations.…

33rd Electric Vehicle Symposium and Exposition scheduled for June 14-17 in Portland, Oregon

WASHINGTON, March 31, 2020 (GLOBE NEWSWIRE) — Siemens AG CEO Joe Kaeser and other key speakers, sponsors and exhibitors from the entire electric drive supply chain, including R&D experts, leading manufacturers, top industry executives and government partners, are slated to participate in the 33rd Electric Vehicle Symposium and Exposition (EVS33), scheduled for June 14 thru 17, 2020, in Portland, Oregon, USA.…

Radient Technologies Inc. Applies to Extend Warrants

EDMONTON, Alberta, March 31, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, has applied to the TSX Venture Exchange (the “TSXV”) to extend the term of 1,070,712 warrants originally scheduled to expire on April 14, 2020 (the “Warrants”) to April 14, 2021.…

Conagen Receives a Strategic Investment from Sumitomo Chemical

Research and development to support the design of clean green chemicals.

Bedford, Mass., March 31, 2020 (GLOBE NEWSWIRE) — Greater Boston-based biotech Conagen has received a strategic investment from Sumitomo Chemical, global chemical company in Japan.…